Quarterly Report

Vir Biotechnology, Inc. Filed 2024-11-04 Acc 0001628280-24-044995

Documents 1

2025-05-08 10-Q Quarterly Report
2024-11-07 4 EVP and General Counsel sold 4,397 shares at $10.11 ($44,454)
2024-11-06 144 Sale of Securities
2024-11-05 144 Sale of Securities
2024-11-05 4 EVP and General Counsel sold 3,750 shares at an average $8.62 ($32,332)
2024-11-04 10-Q Quarterly Report
2024-08-01 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading vir-20240930.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…